The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akin Akinc(Alnylam Pharmaceuticals (United States)), Martin A. Maier(Alnylam Pharmaceuticals (United States)), Muthiah Manoharan(Alnylam Pharmaceuticals (United States)), Kevin Fitzgerald(Alnylam Pharmaceuticals (United States)), Muthusamy Jayaraman(Alnylam Pharmaceuticals (United States)), Scott Barros(Alnylam Pharmaceuticals (United States)), Steven M. Ansell(Acuitas Therapeutics (Canada)), Xinyao Du(Acuitas Therapeutics (Canada)), Michael J. Hope(Acuitas Therapeutics (Canada)), Thomas D. Madden(Acuitas Therapeutics (Canada)), Barbara L. Mui(Acuitas Therapeutics (Canada)), Sean C. Semple(Acuitas Therapeutics (Canada)), Ying K. Tam(Acuitas Therapeutics (Canada)), Marco A. Ciufolini(University of British Columbia), Dominik Witzigmann(University of British Columbia), Jayesh A. Kulkarni(University of British Columbia), Roy van der Meel(University of British Columbia), Pieter R. Cullis(University of British Columbia Hospital)
Cited by 1,549Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis